Next Article in Journal
Effects of Dietary Bacillus amyloliquefaciens SCAU-070 (Based on a Woody Plant-Based Diet) on Antioxidation, Immune and Intestinal Microbiota of Tilapia (Oreochromis niloticus)
Next Article in Special Issue
Contribution of pks+ Escherichia coli (E. coli) to Colon Carcinogenesis
Previous Article in Journal
Development of a Plant-Expressed Subunit Vaccine against Brucellosis
Previous Article in Special Issue
High Detection Frequency of Vaccine-Associated Polioviruses and Non-Polio Enteroviruses in the Stools of Asymptomatic Infants from the Free State Province, South Africa
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Microorganisms
Volume 12
Issue 6
10.3390/microorganisms12061048
microorganisms-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Latent Tuberculosis Infection Is Associated with an Enrichment of Short-Chain Fatty Acid-Producing Bacteria in the Stool of Women Living with HIV

by
Suventha Moodley
1,2,
Elouise Kroon
1,
Charissa C. Naidoo
1,2,
Georgina R. Nyawo
1,2,
Benjamin G. Wu
3,
Selisha Naidoo
1,
Tinaye L. Chiyaka
1,2,
Happy Tshivhula
1,2,
Shivani Singh
3,
Yonghua Li
3,
Robin M. Warren
1,
Eileen G. Hoal
1,
Erwin Schurr
4,5,6,7,
Jose C. Clemente
8,
Leopoldo N. Segal
3,
Marlo Möller
1 and
Grant Theron
1,2,*
1
DSI-NRF Centre of Excellence for Biomedical Tuberculosis Research, SAMRC Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Tygerberg, Cape Town 7505, South Africa
2
African Microbiome Institute, Division of Molecular Biology and Human Genetics, Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town 7505, South Africa
3
Division of Pulmonary and Critical Care Medicine, New York University Grossman School of Medicine, NYU Langone Health, New York, NY 10016, USA
4
Department of Biochemistry, McGill University, Montreal, QC H3A 1Y6, Canada
5
Program in Infectious Diseases and Immunity in Global Health, The Research Institute of the McGill University Health Centre, 1001 Boul Décarie, Site Glen Block E, Room EM3.3210, Montréal, QC H4A 3J1, Canada
6
McGill International TB Centre, McGill University, Montréal, QC H3A3J1, Canada
7
Departments of Medicine and Human Genetics, McGill University, Montréal, QC H3A0C7, Canada
8
Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA
*
Author to whom correspondence should be addressed.
Microorganisms 2024, 12(6), 1048; https://doi.org/10.3390/microorganisms12061048
Submission received: 12 April 2024 / Revised: 10 May 2024 / Accepted: 14 May 2024 / Published: 22 May 2024
(This article belongs to the Special Issue Effects of Gut Microbiota on Human Health and Disease)
Browse Figures
Versions Notes

Abstract

:
Latent tuberculosis infection (LTBI) is common in people living with HIV (PLHIV) in high-TB-burden settings. Active TB is associated with specific stool taxa; however, little is known about the stool microbiota and LTBI in PLHIV. We characterised the stool microbiota of PLHIV with [interferon-γ release assay (IGRA)- and tuberculin skin test (TST)-positive] or without (IGRA- and TST-negative) LTBI (n = 25 per group). The 16S rRNA DNA sequences were analysed using QIIME2, Dirichlet-Multinomial Mixtures, DESeq2, and PICRUSt2. No α- or β-diversity differences occurred by LTBI status; however, LTBI-positive people were Faecalibacterium-, Blautia-, Gemmiger-, and Bacteroides-enriched and Moryella-, Atopobium-, Corynebacterium-, and Streptococcus-depleted. Inferred metagenome data showed that LTBI-negative-enriched pathways included several metabolite degradation pathways. Stool from LTBI-positive people demonstrated differential taxa abundance based on a quantitative response to antigen stimulation. In LTBI-positive people, older people had different β-diversities than younger people, whereas in LTBI-negative people, no differences occurred across age groups. Amongst female PLHIV, those with LTBI were, vs. those without LTBI, Faecalibacterium-, Blautia-, Gemmiger-, and Bacteriodes-enriched, which are producers of short-chain fatty acids. Taxonomic differences amongst people with LTBI occurred according to quantitative response to antigen stimulation and age. These data enhance our understanding of the microbiome’s potential role in LTBI.

1. Introduction

Tuberculosis (TB) is a major cause of death, with 167,000 deaths among persons living with HIV (PLHIV) in 2022 [1]. One strategy to prevent active TB is to control latent tuberculosis infection (LTBI). LTBI is inferred from a positive tuberculin skin test (TST) or interferon-gamma release assay (IGRA). TB preventive treatment (TPT) strategies play a key role in TB prevention especially in vulnerable populations such as PLHIV. PLHIV are at greater risk for Mycobacterium tuberculosis (MTB) infection and progression to active TB [2]. However, it is poorly understood why some individuals in TB-endemic countries are never infected despite high exposure and why a large proportion of infected individuals never progress [3,4]. We need more information on the correlates of infection and progression, which may have prognostic value.
The microbiome has important immunomodulating effects, and the microbiome’s role, including in people with LTBI, is an emerging area of interest. For example, in the lung, Lactobacillus is enriched in people with LTBI compared to the active pulmonary TB group and LTBI-negative people [5]. In the nasopharynx of LTBI-positive people, Staphylococcus and Corynebacterium dominate the microbiome compared to healthy control and active TB cases [6], and the nasopharyngeal microbiota of LTBI-positive people has lower alpha-diversity than that of LTBI-negative people [7]. The stool microbiota has potentially an important immunomodulatory role in respiratory disease, including active TB [8]. However, it is comparatively understudied in latent TB. One study among individuals with poorly controlled diabetes showed LTBI-positive people to be Bacteroides-, Alistipes-, and Blautia-enriched compared to LTBI-negative people [9]. During LTBI infection, comparisons of TB cases, HIV-negative LTBI-positive individuals, and LTBI-negative and active TB gut microbiomes showed trends of changes in Bacteroides and Firmicutes; however, no significant difference was observed in the composition of the stool microbiota [10]. HIV-negative LTBI-positive individuals showed a positive correlation between relative abundances of Coriobacteriaceae and IFN-gamma against MTB antigens more likely associated with CD4+ T cells [11]. A key knowledge gap still exists because those studies did not include PLHIV. Not only is HIV associated with reductions in the diversity in the stool microbiota [12], but PLHIV also have higher rates of TB infection and progression. If microbial dysbiosis is detected early after exposure, it may be indicative of early microbial and immune dysregulation associated with incident TB. Biomarkers of progression to active TB are a major public health priority, as is understanding the biological drivers of LTBI and progression. Therefore, to address these knowledge gaps, we evaluated the stool microbiota of PLHIV with and without LTBI. We hypothesised that taxonomic differences will be seen between PLHIV with and without LTBI.

2. Methods

2.1. Recruitment

Participants (18–60 years) were recruited from community health care clinics in Cape Town, South Africa, as part of a published parent study (ResisTB) [13]. This cohort was predominantly female, and age was a surrogate for TB exposure, resulting in two groups of 18–25 years and 35–60 years. The participants were recruited in the Western Cape, a high-TB-incidence area where 80–90% of the population between 31 and 35 years old display TST reactions >10 mm [14,15]. The parent study used age as a surrogate for cumulative exposure, recruiting adults with extreme ages into two groups (18–25 or 35–60 years old). All people had to be TB-symptom-screen-negative, HIV-positive, and stable on ART for ≥1 year. Study procedures were approved by the Stellenbosch University Human Research Ethics Committee (N16/03/033A), and each participant provided written informed consent.

2.2. Definitions

IGRA- and TST-positive (LTBI-positive) people were defined by two positive QuantiFERON-TB Gold Plus tests and a positive TST (>0 mm). IGRA- and TST-negative (LTBI-negative) people were defined by two negative QuantiFERON-TB Gold Plus tests and a TST (0 mm).

2.3. Microbiota Specimen Collection and Processing

At TST administration, participants were provided with a home stool sampling kit containing an EasySampler (ALPCO, Salem, NH, USA) and a receptacle containing DNA stabilisation buffer (Stratec Biomedical, Birkenfeld, Germany). Generally, buffered stools were collected the night before TST reading and returned at TST reading. Upon receipt at the laboratory, buffered stool was frozen at −20 °C until batched DNA extraction was carried out using the PSP Spin Stool DNA Plus Kit (Stratec Biomedical, Birkenfeld, Germany).

2.4. 16S rRNA Gene Sequencing and Microbiota Analysis

V4 region sequencing of the bacterial 16S rRNA gene (150 bp read length, paired-end) was conducted using Illumina Miseq (Illumina, San Diego, CA, USA), as described in [8]. Sequences was analysed with Quantitative Insights into Microbial Ecology (QIIME2, version 2.0.8). Cluster analysis was carried out using Dirichlet-Multinomial Mixtures (DMM) [16]. Alpha-diversity was calculated by Shannon’s diversity with Mann–Whitney testing using GraphPad Prism (v8 GraphPad Software, Boston, MA, USA). Beta-diversity was calculated using Bray–Curtis with permutational multivariate ANOVA (PERMANOVA) using R (v4.2.2). Functional metagenome was inferred from sequencing data using Phylogenetic Investigation of Communities by Reconstruction of Unobserved States (PICRUSt2; V.2.1.3-b) [17]. Differentially abundant taxa and metabolic pathways were identified using DESeq2 (v1.22.2) [18] and Benjamini–Hochberg correction adjustment for multiple comparisons (significance level 0.20) [8,19]. For comparison groups, taxa at higher relative abundance in one group were described as enriched (those at lower relative abundance were described as depleted). For the whole cohort, age and field site correction was applied for DESeq2 analyses. Linear discriminant analysis (LDA) effect size (LEfSe) [20] was used to compare the clusters to each other. The proportions test was performed using STATA (v18; StataCorp, College Station, TX, USA) to determine whether a specific variable was more frequent in different groups.

3. Results

3.1. Population

We collected stool from female PLHIV stable on ART who did not have previous TB, with or without LTBI (n = 25 per group; Figure 1). Demographic data are shown in Table 1. People with LTBI were younger and more likely to be from Khayelitsha (Site B) Community Health Clinic (Table 1).

3.2. Stool from People with LTBI Is Moryella-, Atopobium-, Corynebacterium-, and Streptococcus-Depleted and Faecalibacterium-, Blautia-, Gemmiger-, and Bacteroides-Enriched

Overall, no differences were seen by LTBI status for α- (p = 0.168, Figure 2A) and β-diversity (PERMANOVA, p = 0.841, Figure 2B). However, Moryella, Atopobium, Corynebacterium, and Streptococcus were depleted and Faecalibacterium, Blautia, Gemmiger, and Bacteroides were enriched in LTBI-positive people compared to LTBI-negative people (Figure 2C). People on TB preventative treatment (INH prophylaxis) were, compared to those not on treatment, Blautia-enriched and Moraxella-, Megamonas-, and Actinobacillus-depleted (Supplementary Figure S1).

3.3. Comparisons According to Age Groups (18–25 vs. 35–60 Years)

When we compared age groups within people of the same LTBI status, within LTBI-positive individuals, no α-diversity differences occurred (p = 0.789, Figure 3A); however, the β-diversity differed (p = 0.003, Figure 3B). Older LTBI-positive people were Ochorobactrum-, Neisseria-, and Mycoplasma-enriched and Catenibacterium-, Alistipes-, and Methanobrevibacter-depleted (Figure 3C). LTBI-negative individuals did not differ in α-diversity (p = 0.205, Figure 3D) or β-diversity (p = 0.442, Figure 3E), and older LTBI-negative people were also Methanobrevibacter-depleted and Actinobacillus-enriched. (Figure 3F). We calculated the Bray–Curtis distances for older vs. younger LTBI-positive and LTBI-negative people. Both age groups demonstrated similar distances (p = 0.952) across LTBI statuses (Supplementary Figure S2).

3.4. Distinct Metabolic Pathway Associations with LTBI-Positive and -Negative People

LTBI-negative people were enriched in the methylglyoxal, L-arginine, putrescine, 4-aminobutanoate, and L-ornithine degradation pathways (Figure 4). LTBI-positive people had no differential enrichment.

3.5. Microbial Cluster Identification and Their Characteristics

Taxonomic analyses: Three clusters (C1, C2, and C3) were identified (Supplementary Figure S3) with C1 vs. C2 (p = 0.361) and C2 vs. C3 (p = 0.299) having similar α-diversity whilst C1 vs. C3 differed (p = 0.040) (Figure 5A). The β-diversity differed between clusters (PERMANOVA p = 0.001) (Figure 5B). C1, C2, and C3 were characterised by high Bacteriodes, Streptococcus, and Prevotella abundances, respectively (Figure 5C). When cluster pairs were compared (Figure 5D–F), C1 was, compared to C2, Methanobrevibacter-, Catenibacterium-, and Megamonas-enriched and Actinobacillus-, Moraxella-, and Ochrobactrum-depleted and, compared to C3, Megamonas-, Akkermansia-, and Anaerostipes-enriched and Succinivibrio-, Prevotella-, and Dialister-depleted. C3 was, compared to C2, Roseburia-, Anaerovibrio-, and CF231-enriched and Actinobacillus-, Moraxella-, and Ochrobactrum-depleted. When all three clusters were compared together (Supplementary Figure S4), C1 was, relative to the others, the most enriched in Bacteroides, Oscillospirai, and Parabacteroides. C2 was the most enriched in Streptococcus, Veillonella, and Actinomyces, and C3 was the most enriched in Prevotella and Catenibacterium.
Clinical and demographic characteristics across clusters: β-diversity differed by field site (Supplementary Table S1). There were no differences in the proportion of LTBI-positive people per cluster (Table 2). People in C1 and C3 were more likely to be on INH prophylaxis than C2 and more likely to be from sites other than Khayelitsha (Site B) Youth. People in C2 were, compared to those in C3, more likely to be from sites other than Khayelitsha (Site B) CHC Youth and Du Noon CDC.

3.6. Within LTBI-Positive People, Taxa Are Differentially Enriched Based on the Magnitude of the Response to Antigen Stimulation

Taxonomic abundances between quantitative responses to antigen stimulation were compared overall and in LTBI-positive people. No differential abundances were identified between the overall cohort above or vs. the median average IGRA or TST quantitative response (Supplementary Figure S5A,B). LTBI-positive people with an IGRA response above the median were Acidaminococcus-enriched and Granulicatella-depleted (Figure 6A), and LTBI-positive people below the median TST response were Megamonas-, Alistipes-, and Paraprevotella-enriched (Figure 6B).

4. Discussion

We compared, in PLHIV, the stool microbiota of LTBI-positive vs. LTBI-negative women. Our key findings are as follows: (1) the stool from LTBI-positive people differed from that of LTBI-negative people in terms of known short-chain fatty acid (SCFA)-producing taxa, and these were associated with a depletion of metabolite degradation pathways; (2) three taxonomic clusters occurred, characterised by high abundances of Bacteroides, Streptococcus, and Prevotella and clustering associated with INH prophylaxis and health facility location; (3) LTBI-positive people with a greater quantitative response to mycobacterial antigen stimulation were, vs. LTBI-positive people with lesser responses, Acidaminococcus-enriched (IGRA readouts) and Megamonas-, Alistipes-, and Paraprevotella-depleted (TST); and (4) the β-diversity differed by age group only in LTBI-positive people. Our findings help lay a foundation for understanding the microbiome’s role in LTBI. Stool from people with LTBI was Moryella-, Atopobium-, Corynebacterium-, and Streptococcus-depleted and Faecalibacterium-, Blautia-, Gemmiger-, and Bacteroides-enriched. Faecalibacterium and Gemmiger are known producers of butyrate [21], which is an SCFA that increases incident TB risk [22]. Bacteroides produces SCFAs like acetate and propionate [23]. Blautia is enriched in people with active TB and independently predicts the upregulation of proinflammatory pathways [8]. Although the role of Atopobium is unclear, Streptococcus, which we found to be depleted in LTBI-positive people, produces acetate, which mitigates host inflammation [24].
Three taxonomic clusters occurred [Bacteroides (C1), Streptococcus (C2), Prevotella-enriched (C3)]; however, these were not associated with LTBI status (other studies have documented specific clusters associated with active TB [19]). People within each cluster were more likely to be recruited from different facilities, suggesting potential geographic associations to be considered in future studies. Additionally, C1 was more likely than C2 to be receiving INH prophylaxis. INH prophylaxis itself was associated with Blautia enrichment and Moraxella, Megamonas, and Actinobacillus depletion. Other studies have shown Clostridiales-, Coprococcus-, Lachnospiraceae-, and Ruminococcaceae-enriched and Clostridium_XIVa-, Romboutsia-, and Roseburia-depleted stool to occur during rifamycin-based tuberculosis preventive therapy [25]. To our knowledge, our study is the first to show Blautia-enriched and Moraxella-, Megamonas-, and Actinobacillus-depleted stool in humans on isoniazid TB preventive therapy. This association is interesting as isoniazid itself is a drug thought to have an extremely narrow antimicrobial spectrum (Mycobacteria only) [26].
Additionally, LTBI-positive people who had a larger quantitative response to antigen stimulation were, when IGRA readouts were used, Acidaminococcus-enriched and Granulicatella-depleted and, when TST readouts were used, Megamonas-, Alistipes-, and Paraprevotella-depleted. Acidaminococcus produces acetate and butyrate [27] and is primarily influenced by diet [28]; its enrichment likely reflects lifestyle differences within LTBI-positive people. Paraprevotella (like Alistipes) is an SCFA producer and is generally considered beneficial [29]. This finding is notable because higher quantitative responses are associated with a greater risk of incident TB [30], suggesting such taxa may contribute to this risk; however, this requires prospective confirmation in controlled studies. Younger people were more likely to be LTBI-positive than older people, so, to adjust for age as a potential confounder, we dichotomised people (18–25 and 35–60 years). Within LTBI-positive people, older vs. younger individuals were enriched in Ochrobactrum (an opportunistic pathogen [31]), Neisseria (role unclear), and Mycoplasma (induces a proinflammatory cytokines [32]) and depleted in Catenibacterium (enriched in PLHIV [33] and active TB [34]), Alistipes (SCFA producer with potentially anti-inflammatory effects [35]), and Methanobrevibacter (a methane producer [36]). Older LTBI-negative people were also Methanobrevibacter-depleted and enriched in Actinobacillus (inversely associated with amino acid production [37]) but did not show β-diversity differences. This could suggest that LTBI results in greater age-related microbiome differences but requires further investigation.
Our study has strengths and limitations. This is a cross-sectional study that, to enhance feasibility, leveraged (but was constrained to) the parent ResisTB study. We only evaluated women with HIV, and other populations may result in different findings; however, PLHIV do have an elevated risk of incident TB. People aged 26–34 were not recruited by the parent study and were hence unavailable to us. This may affect our findings. Although people were measured once, our study generates useful data to inform hypothesis-driven interventions to potentially modulate the microbiome. In conclusion, amongst women living with HIV, those with LTBI were, vs. those without LTBI, primarily differentially abundant in SCFA-producing anaerobic bacteria. Taxonomic differences also occurred amongst people with LTBI by age group, suggesting that age-related microbiome perturbations are more pronounced in LTBI-positive people. Whether the taxonomic associations with TB infection identified here influence or play a casual role in TB progression requires future research. Longitudinal studies are needed to further delineate the microbiome’s role in LTBI, which this work helps provide a justification for.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/microorganisms12061048/s1, Figure S1: People who received INH prophylaxis were Blautia-enriched and Moraxella-, Megamonas- and Actinobacillus-depleted. Volcano plot depicting differentially abundant taxa based on INH prophylaxis. More discriminatory taxa appear closer to the left or right, and higher above the threshold (red dotted line, FDR = 0.20). Figure S2. Bray–Curtis distances between 35–60 and 18–25 in LTBI-positives vs LTBI-negatives are similar. Bray–Curtis distances between 35-60 and 18–25 in LTBI-positives vs LTBI-negatives, where similar distances indicate less dissimilarity. LTBI: Latent TB infection. Figure S3: The DMM LaPlace approximation. Three clusters were identified as the best fit using Dirichlet-Multinomial Mixtures (DMM) in the stool samples collected in the overall cohort. Figure S4: Taxonomic differences between the three clusters found in the cohort. (A) Linear discriminant analysis (LDA) effect size (LEfSe) identified significant taxonomic differences in microbiome enrichment based on clusters. (B) Relative abundance of each genus. Figure S5: No difference between taxa associated with quantitative response to antigen stimulation. (A) Volcano plot depicting differentially abundant taxa based on the median IGRA quantitative response to antigen (median value 0.43). More discriminatory taxa appear closer to the left or right, and higher above the threshold (red dotted line, FDR = 0.20). (B) Volcano plot depicting differentially abundant taxa based on the median TST response (Median value 25). LTBI: Latent TB infection. Table S1: Alpha and Beta diversity compared by cohort characteristics. In addition to the age differences seen in Figure 2, β-diversity differences were seen between field sites.

Author Contributions

S.M., C.C.N. and G.T. contributed to the study design, supervision of this study, and data collection and wrote this manuscript. All authors contributed to the interpretation of data analysis and the editing of this manuscript. All authors have read and agreed to the published version of the manuscript.

Funding

This work and its authors were supported by the Deutscher Akademischer Austauschdienst (ST32-PKZ-91770486), the European & Developing Countries Clinical Trials Partnership (EDCTP; project numbers SF1041, TMA2017CDF-1914-MOSAIC, and TMA2019CDF-2738-ESKAPE-TB), National Research Foundation (NRF), the South African Medical Research Council (SAMRC), the Harry Crossley Foundation, Stellenbosch University Faculty of Health Sciences, and the National Institute of Allergy and Infectious Diseases of the National Institutes of Health under award numbers R01AI136894; U01AI152087; U54EB027049; D43TW010350; and K43TW012302. The content is the solely the responsibility of the authors and does not necessarily represent the official views of the funders.

Institutional Review Board Statement

Study procedures were approved by the Stellenbosch University Human Research Ethics Committee (N16/03/033A), and each participant provided written informed consent. HREC is committed to the ethical principles laid down in the South African and international guidelines, Declaration of Helsinki, Declaration of Taipei, and The Belmont Report.

Informed Consent Statement

People provided written informed consent to participate in this study.

Data Availability Statement

Sequences are available in the Sequence Read Archive (PRJNA1113869). Data and R scripts used for analyses are publicly available upon publication. The original contributions presented in the study are included in the article/Supplementary Material, further inquiries can be directed to the corresponding author.

Acknowledgments

The authors thank the study participants and CLIME research group staff. Computations were performed using facilities provided by the University of Cape Town’s ICTS High Performance Computing team: https://ucthpc.uct.ac.za/.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. World Health Organization. Global Tuberculosis Report; WHO: Geneva, Switzerland, 2023. [Google Scholar]
  2. Churchyard, G.J.; Fielding, K.L.; Lewis, J.J.; Coetzee, L.; Corbett, E.L.; Godfrey-Faussett, P.; Hayes, R.J.; Chaisson, R.E.; Grant, A.D. A trial of mass isoniazid preventive therapy for tuberculosis control. N. Engl. J. Med. 2014, 370, 301–310. [Google Scholar] [CrossRef] [PubMed]
  3. Simmons, J.D.; Stein, C.M.; Seshadri, C.; Campo, M.; Alter, G.; Fortune, S.; Schurr, E.; Wallis, R.S.; Churchyard, G.; Mayanja-Kizza, H. Immunological mechanisms of human resistance to persistent Mycobacterium tuberculosis infection. Nat. Rev. Immunol. 2018, 18, 575–589. [Google Scholar] [CrossRef] [PubMed]
  4. Gutierrez, J.; Kroon, E.E.; Möller, M.; Stein, C.M. Phenotype definition for “resisters” to Mycobacterium tuberculosis infection in the literature—A review and recommendations. Front. Immunol. 2021, 12, 619988. [Google Scholar] [CrossRef] [PubMed]
  5. Zhang, M.; Shen, L.; Zhou, X.; Chen, H. The microbiota of human lung of pulmonary tuberculosis and the alteration caused by anti-tuberculosis drugs. Curr. Microbiol. 2022, 79, 321. [Google Scholar] [CrossRef] [PubMed]
  6. Huang, Y.; Tang, J.-H.; Cai, Z.; Qi, Y.; Jiang, S.; Ma, T.-T.; Yue, Y.; Huang, F.; Yang, H.; Ma, Y.-Y. Alterations in the nasopharyngeal microbiota associated with active and latent tuberculosis. Tuberculosis 2022, 136, 102231. [Google Scholar] [CrossRef] [PubMed]
  7. Ruiz-Tagle, C.; Ugalde, J.A.; Naves, R.; Araos, R.; García, P.; Balcells, M.E. Reduced microbial diversity of the nasopharyngeal microbiome in household contacts with latent tuberculosis infection. Sci. Rep. 2023, 13, 7301. [Google Scholar] [CrossRef] [PubMed]
  8. Naidoo, C.C.; Nyawo, G.R.; Sulaiman, I.; Wu, B.G.; Turner, C.T.; Bu, K.; Palmer, Z.; Li, Y.; Reeve, B.W.; Moodley, S. Anaerobe-enriched gut microbiota predicts pro-inflammatory responses in pulmonary tuberculosis. EBioMedicine 2021, 67, 103374. [Google Scholar] [CrossRef] [PubMed]
  9. Huang, H.-L.; Luo, Y.-C.; Lu, P.-L.; Huang, C.-H.; Lin, K.-D.; Lee, M.-R.; Cheng, M.-H.; Yeh, Y.-T.; Kao, C.-Y.; Wang, J.-Y. Gut microbiota composition can reflect immune responses of latent tuberculosis infection in patients with poorly controlled diabetes. Respir. Res. 2023, 24, 11. [Google Scholar] [CrossRef]
  10. Hu, Y.; Yang, Q.; Liu, B.; Dong, J.; Sun, L.; Zhu, Y.; Su, H.; Yang, J.; Yang, F.; Chen, X. Gut microbiota associated with pulmonary tuberculosis and dysbiosis caused by anti-tuberculosis drugs. J. Infect. 2019, 78, 317–322. [Google Scholar] [CrossRef]
  11. Huang, S.F.; Yang, Y.Y.; Chou, K.T.; Fung, C.P.; Wang, F.D.; Su, W.J. Systemic proinflammation after Mycobacterium tuberculosis infection was correlated to the gut microbiome in HIV-uninfected humans. Eur. J. Clin. Investig. 2019, 49, e13068. [Google Scholar] [CrossRef]
  12. Nowak, P.; Troseid, M.; Avershina, E.; Barqasho, B.; Neogi, U.; Holm, K.; Hov, J.R.; Noyan, K.; Vesterbacka, J.; Svärd, J. Gut microbiota diversity predicts immune status in HIV-1 infection. Aids 2015, 29, 2409–2418. [Google Scholar] [CrossRef] [PubMed]
  13. Kroon, E.E.; Kinnear, C.J.; Orlova, M.; Fischinger, S.; Shin, S.; Boolay, S.; Walzl, G.; Jacobs, A.; Wilkinson, R.J.; Alter, G. An observational study identifying highly tuberculosis-exposed, HIV-1-positive but persistently TB, tuberculin and IGRA negative persons with M. tuberculosis specific antibodies in Cape Town, South Africa. EBioMedicine 2020, 61, 103053. [Google Scholar] [CrossRef] [PubMed]
  14. Wood, R.; Liang, H.; Wu, H.; Middelkoop, K.; Oni, T.; Rangaka, M.X.; Wilkinson, R.J.; Bekker, L.-G.; Lawn, S.D. Changing prevalence of tuberculosis infection with increasing age in high-burden townships in South Africa. Int. J. Tuberc. Lung Dis. 2010, 14, 406–412. [Google Scholar] [PubMed]
  15. Gallant, C.; Cobat, A.; Simkin, L.; Black, G.; Stanley, K.; Hughes, J.; Doherty, T.; Hanekom, W.; Eley, B.; Beyers, N. Impact of age and sex on mycobacterial immunity in an area of high tuberculosis incidence. Int. J. Tuberc. Lung Dis. 2010, 14, 952–959. [Google Scholar]
  16. Holmes, I.; Harris, K.; Quince, C. Dirichlet multinomial mixtures: Generative models for microbial metagenomics. PLoS ONE 2012, 7, e30126. [Google Scholar] [CrossRef] [PubMed]
  17. Douglas, G.M.; Maffei, V.J.; Zaneveld, J.R.; Yurgel, S.N.; Brown, J.R.; Taylor, C.M.; Huttenhower, C.; Langille, M.G. PICRUSt2 for prediction of metagenome functions. Nat. Biotechnol. 2020, 38, 685–688. [Google Scholar] [CrossRef] [PubMed]
  18. Love, M.I.; Huber, W.; Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014, 15, 1–21. [Google Scholar] [CrossRef]
  19. Nyawo, G.R.; Naidoo, C.C.; Wu, B.; Sulaiman, I.; Clemente, J.C.; Li, Y.; Minnies, S.; Reeve, B.W.; Moodley, S.; Rautenbach, C. More than Mycobacterium tuberculosis: Site-of-disease microbial communities, and their functional and clinical profiles in tuberculous lymphadenitis. Thorax 2023, 78, 297–308. [Google Scholar] [CrossRef] [PubMed]
  20. Segata, N.; Izard, J.; Waldron, L.; Gevers, D.; Miropolsky, L.; Garrett, W.S.; Huttenhower, C. Metagenomic biomarker discovery and explanation. Genome Biol. 2011, 12, R60. [Google Scholar] [CrossRef]
  21. Meng, X.; Shu, Q. Novel primers to identify a wider diversity of butyrate-producing bacteria. World J. Microbiol. Biotechnol. 2024, 40, 76. [Google Scholar] [CrossRef]
  22. Segal, L.N.; Clemente, J.C.; Li, Y.; Ruan, C.; Cao, J.; Danckers, M.; Morris, A.; Tapyrik, S.; Wu, B.G.; Diaz, P. Anaerobic Bacterial Fermentation Products Increase Tuberculosis Risk in Antiretroviral-Drug-Treated HIV Patients. Cell Host Microbe 2017, 21, 530–537.e4. [Google Scholar] [CrossRef]
  23. Fu, X.; Liu, Z.; Zhu, C.; Mou, H.; Kong, Q. Nondigestible carbohydrates, butyrate, and butyrate-producing bacteria. Crit. Rev. Food Sci. Nutr. 2019, 59, S130–S152. [Google Scholar] [CrossRef] [PubMed]
  24. Vitetta, L.; Llewellyn, H.; Oldfield, D. Gut Dysbiosis and the Intestinal Microbiome: Streptococcus thermophilus a Key Probiotic for Reducing Uremia. Microorganisms 2019, 7, 228. [Google Scholar] [CrossRef] [PubMed]
  25. Séraphin, M.N.; Bellot, J.; Klann, E.; Ukhanova, M.; Saulsberry, F.G.; Peloquin, C.A.; Mai, V. Gut microbiota composition and diversity before, during, and two months after rifamycin-based tuberculosis preventive therapy. Sci. Rep. 2023, 13, 18933. [Google Scholar] [CrossRef] [PubMed]
  26. Naidoo, C.C.; Nyawo, G.R.; Wu, B.G.; Walzl, G.; Warren, R.M.; Segal, L.N.; Theron, G. The microbiome and tuberculosis: State of the art, potential applications, and defining the clinical research agenda. Lancet Respir. Med. 2019, 7, 892–906. [Google Scholar] [CrossRef] [PubMed]
  27. Buckel, W.; Barker, H. Two pathways of glutamate fermentation by anaerobic bacteria. J. Bacteriol. 1974, 117, 1248–1260. [Google Scholar] [CrossRef] [PubMed]
  28. Zheng, J.; Hoffman, K.L.; Chen, J.-S.; Shivappa, N.; Sood, A.; Browman, G.J.; Dirba, D.D.; Hanash, S.; Wei, P.; Hebert, J.R. Dietary inflammatory potential in relation to the gut microbiome: Results from a cross-sectional study. Br. J. Nutr. 2020, 124, 931–942. [Google Scholar] [CrossRef] [PubMed]
  29. Bai, J.; Li, Y.; Zhang, W.; Fan, M.; Qian, H.; Zhang, H.; Qi, X.; Wang, L. Source of gut microbiota determines oat β-glucan degradation and short chain fatty acid-producing pathway. Food Biosci. 2021, 41, 101010. [Google Scholar] [CrossRef]
  30. Hamada, Y.; Gupta, R.K.; Quartagno, M.; Izzard, A.; Acuna-Villaorduna, C.; Altet, N.; Diel, R.; Dominguez, J.; Floyd, S.; Gupta, A. Predictive performance of interferon-gamma release assays and the tuberculin skin test for incident tuberculosis: An individual participant data meta-analysis. EClinicalMedicine 2023, 56, 101815. [Google Scholar] [CrossRef]
  31. Ryan, M.P.; Pembroke, J.T. The genus Ochrobactrum as major opportunistic pathogens. Microorganisms 2020, 8, 1797. [Google Scholar] [CrossRef]
  32. Chen, W.; Li, D.; Paulus, B.; Wilson, I.; Chadwick, V.S. High prevalence of Mycoplasma pneumoniae in intestinal mucosal biopsies from patients with inflammatory bowel disease and controls. Dig. Dis. Sci. 2001, 46, 2529–2535. [Google Scholar] [CrossRef]
  33. Duvallet, C.; Gibbons, S.M.; Gurry, T.; Irizarry, R.A.; Alm, E.J. Meta-analysis of gut microbiome studies identifies disease-specific and shared responses. Nat. Commun. 2017, 8, 1784. [Google Scholar] [CrossRef] [PubMed]
  34. Khaliq, A.; Ravindran, R.; Afzal, S.; Jena, P.K.; Akhtar, M.W.; Ambreen, A.; Wan, Y.-J.Y.; Malik, K.A.; Irfan, M.; Khan, I.H. Gut microbiome dysbiosis and correlation with blood biomarkers in active-tuberculosis in endemic setting. PLoS ONE 2021, 16, e0245534. [Google Scholar] [CrossRef] [PubMed]
  35. Oliphant, K.; Allen-Vercoe, E. Macronutrient metabolism by the human gut microbiome: Major fermentation by-products and their impact on host health. Microbiome 2019, 7, 91. [Google Scholar] [CrossRef] [PubMed]
  36. Matarazzo, F.; Ribeiro, A.; Faveri, M.D.; Taddei, C.; Martinez, M.B.; Mayer, M.P.A. The domain Archaea in human mucosal surfaces. Clin. Microbiol. Infect. 2012, 18, 834–840. [Google Scholar] [CrossRef]
  37. Ling, C.-W.; Miao, Z.; Xiao, M.-L.; Zhou, H.; Jiang, Z.; Fu, Y.; Xiong, F.; Zuo, L.-S.-Y.; Liu, Y.-P.; Wu, Y.-Y. The association of gut microbiota with osteoporosis is mediated by amino acid metabolism: Multiomics in a large cohort. J. Clin. Endocrinol. Metab. 2021, 106, e3852–e3864. [Google Scholar] [CrossRef]
Microorganisms 12 01048 g001
Figure 1. Study flow diagram. We collected and analysed stool from 25 LTBI-positive and 25 LTBI-negative people enrolled in a parent study (ResisTB). Abbreviations: ART: antiretroviral therapy; HIV: human immunodeficiency virus; IGRA: interferon-gamma release assay; TST: tuberculin skin test; LTBI: latent TB infection; TB: tuberculosis.
Figure 1. Study flow diagram. We collected and analysed stool from 25 LTBI-positive and 25 LTBI-negative people enrolled in a parent study (ResisTB). Abbreviations: ART: antiretroviral therapy; HIV: human immunodeficiency virus; IGRA: interferon-gamma release assay; TST: tuberculin skin test; LTBI: latent TB infection; TB: tuberculosis.
Microorganisms 12 01048 g001
Microorganisms 12 01048 g002
Figure 2. Stool from LTBI-positive people is Moryella-, Atopobium-, Corynebacterium-, and Streptococcus-depleted and Faecalibacterium-, Blautia-, Gemmiger-, and Bacteroides-enriched. (A) Comparison of Shannon’s diversity index of LTBI-positive and LTBI-negative groups. (B) Principal coordinate analysis of Bray–Curtis distances between groups. (C) Volcano plot depicting differentially abundant taxa. More discriminatory taxa (bolded) appear closer to the left or right and higher above the threshold (red dotted line, FDR = 0.20). Relative abundance of taxa is indicated by circle size. The blue circles are taxa below the selected threshold. Abbreviation: LTBI: latent TB infection.
Figure 2. Stool from LTBI-positive people is Moryella-, Atopobium-, Corynebacterium-, and Streptococcus-depleted and Faecalibacterium-, Blautia-, Gemmiger-, and Bacteroides-enriched. (A) Comparison of Shannon’s diversity index of LTBI-positive and LTBI-negative groups. (B) Principal coordinate analysis of Bray–Curtis distances between groups. (C) Volcano plot depicting differentially abundant taxa. More discriminatory taxa (bolded) appear closer to the left or right and higher above the threshold (red dotted line, FDR = 0.20). Relative abundance of taxa is indicated by circle size. The blue circles are taxa below the selected threshold. Abbreviation: LTBI: latent TB infection.
Microorganisms 12 01048 g002
Microorganisms 12 01048 g003
Figure 3. Distinct stool microbiotas by age in LTBI-positive people. Shannon’s diversity index, principal coordinate analysis of Bray–Curtis distances, and volcano plot depicting differentially abundant taxa enriched in 35–60 and 18–25 age groups are for LTBI-positive people only (A–C) and for LTBI-negative people only (D–F). More discriminatory taxa (bolded) appear closer to the left or right and higher above the threshold (red dotted line, FDR = 0.20). Relative abundance of taxa is indicated by circle size. The blue circles are taxa below the selected threshold. Abbreviation: LTBI: latent TB infection.
Figure 3. Distinct stool microbiotas by age in LTBI-positive people. Shannon’s diversity index, principal coordinate analysis of Bray–Curtis distances, and volcano plot depicting differentially abundant taxa enriched in 35–60 and 18–25 age groups are for LTBI-positive people only (A–C) and for LTBI-negative people only (D–F). More discriminatory taxa (bolded) appear closer to the left or right and higher above the threshold (red dotted line, FDR = 0.20). Relative abundance of taxa is indicated by circle size. The blue circles are taxa below the selected threshold. Abbreviation: LTBI: latent TB infection.
Microorganisms 12 01048 g003
Microorganisms 12 01048 g004
Figure 4. Distinct microbial metabolic pathways are associated with LTBI. LTBI-positive people had a depletion of degradation-associated pathways. More discriminatory pathways (bolded) appear closer to the left or right and higher above the threshold (red dotted line, FDR = 0.20). The blue circles are pathways below the selected threshold. Abbreviation: LTBI: latent TB infection.
Figure 4. Distinct microbial metabolic pathways are associated with LTBI. LTBI-positive people had a depletion of degradation-associated pathways. More discriminatory pathways (bolded) appear closer to the left or right and higher above the threshold (red dotted line, FDR = 0.20). The blue circles are pathways below the selected threshold. Abbreviation: LTBI: latent TB infection.
Microorganisms 12 01048 g004
Microorganisms 12 01048 g005
Figure 5. Three distinct microbial clusters with a high abundance of Bacteroides, Streptococcus, and Prevotella were identified. Comparison of (A) alpha- and (B) beta-diversity by cluster. (C) Heatmap shows the composition of each cluster. (D–F) Volcano plots depicting differentially abundant taxa compared across cluster pairs. More discriminatory taxa (bolded) appear closer to the left or right and higher above the threshold (red dotted line, FDR = 0.20). The blue circles are pathways below the selected threshold. Abbreviation: LTBI: latent TB infection.
Figure 5. Three distinct microbial clusters with a high abundance of Bacteroides, Streptococcus, and Prevotella were identified. Comparison of (A) alpha- and (B) beta-diversity by cluster. (C) Heatmap shows the composition of each cluster. (D–F) Volcano plots depicting differentially abundant taxa compared across cluster pairs. More discriminatory taxa (bolded) appear closer to the left or right and higher above the threshold (red dotted line, FDR = 0.20). The blue circles are pathways below the selected threshold. Abbreviation: LTBI: latent TB infection.
Microorganisms 12 01048 g005
Microorganisms 12 01048 g006
Figure 6. LTBI-positive people had, based on the magnitude of the quantitative responses, differentially enriched taxa (those with IGRA responses above the median were Acidaminococcus-enriched and Granulicatella-depleted; those with TST responses below the median were Megamonas-, Alistipes-, and Paraprevotella-enriched). (A) Volcano plot depicting differentially abundant taxa based on the median IGRA quantitative response to antigen (median value 5.56). More discriminatory taxa appear closer to the left or right and higher above the threshold (red dotted line, FDR = 0.20). The blue circles are pathways below the selected threshold. (B) Volcano plot depicting differentially abundant taxa based on the median TST response (median value: 18). Abbreviation: LTBI: latent TB infection.
Figure 6. LTBI-positive people had, based on the magnitude of the quantitative responses, differentially enriched taxa (those with IGRA responses above the median were Acidaminococcus-enriched and Granulicatella-depleted; those with TST responses below the median were Megamonas-, Alistipes-, and Paraprevotella-enriched). (A) Volcano plot depicting differentially abundant taxa based on the median IGRA quantitative response to antigen (median value 5.56). More discriminatory taxa appear closer to the left or right and higher above the threshold (red dotted line, FDR = 0.20). The blue circles are pathways below the selected threshold. (B) Volcano plot depicting differentially abundant taxa based on the median TST response (median value: 18). Abbreviation: LTBI: latent TB infection.
Microorganisms 12 01048 g006
Table 1. Demographic and clinical characteristics. People with LTBI were younger and more likely to from Khayelitsha (Site B) CHC. Abbreviations: LTBI: latent TB infection; BMI: body mass index; INH: isoniazid; CHC: Community Health Centre; CDC: Community Day Centre. Data are median (IQR) or n (%).
Table 1. Demographic and clinical characteristics. People with LTBI were younger and more likely to from Khayelitsha (Site B) CHC. Abbreviations: LTBI: latent TB infection; BMI: body mass index; INH: isoniazid; CHC: Community Health Centre; CDC: Community Day Centre. Data are median (IQR) or n (%).
Characteristic * Overall
(n = 50)		LTBI-Positive
(n = 25)		LTBI-Negative
(n = 25)		p-Value
Age, years 24 (23–39)24 (22–25)38 (24–41)0.005
18–25 33/50 (66)21/25 (84)12/25 (48)
35–60 17/50 (34)4/25 (16)13/25 (52)0.007
CD4 (cells/mm3)468 (368–683)471 (346–675)434 (375–705)0.881
BMI (kg/m)29 (25–33)30 (28–34)26 (24–32)0.137
Current Tobacco smoker1/49 (2)0/24 (0)1/25 (4)0.312
Alcohol31/50 (62)17/25 (68)14/25 (56)0.382
INH prophylaxis12/50 (24)6/25 (24)6/25 (24)>0.999
Co-trimoxazole prophylaxis7/50 (14)2/25 (8)5/25 (20)0.221
Field site
Khayelitsha (Site B) CHC10/50 (20)8/25 (32)2/25 (8)0.034
Khayelitsha (Site B) Youth7/50 (14)4/25 (16)3/25 (12)0.684
Kraaifontein CHC11/50 (22)1/25 (4)10/25 (40)0.002
Site C Youth19/50 (38)12/25 (48)7/25 (28)0.145
Du Noon CDC3/50 (12)0/25 (0)3/25 (12)0.074
Bolded p values are significant at p < 0.05. * Missing data: current Tobacco smoker (n = 1).
Table 2. Demographic and clinical characteristics of the three clusters found in cohort. C1 was more likely than C2 to be on current INH prophylaxis and more likely to be recruited from Khayelitsha (Site B) CHC, Kraaifontein CHC, Site C Youth, or Du Noon CDC. C2 was more likely than C3 to be recruited from Khayelitsha (Site B) CHC, Kraaifontein CHC, or Site C Youth. Abbreviations: LTBI: latent TB infection; BMI: body mass index; INH: isoniazid; CHC: Community Health Centre; CDC: Community Day Centre. Data are median (IQR) or n (%).
Table 2. Demographic and clinical characteristics of the three clusters found in cohort. C1 was more likely than C2 to be on current INH prophylaxis and more likely to be recruited from Khayelitsha (Site B) CHC, Kraaifontein CHC, Site C Youth, or Du Noon CDC. C2 was more likely than C3 to be recruited from Khayelitsha (Site B) CHC, Kraaifontein CHC, or Site C Youth. Abbreviations: LTBI: latent TB infection; BMI: body mass index; INH: isoniazid; CHC: Community Health Centre; CDC: Community Day Centre. Data are median (IQR) or n (%).
Characteristics *C1 (n = 23)C2 (n = 16)C3 (n = 11)p-Value
C1 vs. C2		p-Value
C2 vs. C3		p-Value
C1 vs. C3
Age, years24 (22–25)37 (24–40)25 (24–33)0.1140.7230.146
LTBI-positive11/23 (48)9/16 (56)5/11 (46)0.6010.5810.900
CD4 (cells/mm3)575 (375–700)395 (372–516)487 (317–642)0.2420.9140.445
BMI (kg/m)29 (25–32)30 (28–35)27 (23–34)0.2480.2770.612
Current Tobacco smoker 0/23 (0)0/15 (0)1/11 (9)-0.2340.142
Alcohol15/23 (65)9/16 (56)7/11 (64)0.5740.7040.927
INH prophylaxis8/23 (35)1/16 (6)3/11 (27)0.0370.1300.662
Co-trimoxazole prophylaxis3/23 (13)4/16 (25)0/11 (0)0.3370.0720.211
Field site
Khayelitsha (Site B) CHC0/23 (0)10/16 (63)0/11 (0)<0.001<0.001-
Khayelitsha (Site B) Youth1/23 (4)3/16 (19)3/11 (27)0.14400.5970.051
Kraaifontein CHC7/23 (30)0/16 (0)4/11 (36)0.0140.0090.726
Site C Youth15/23 (65)0/16 (0)4/11 (36)<0.0010.0090.114
Du Noon CDC0/23 (0)3/16 (19)0/11 (0)0.0300.127-
Bolded items indicate that p values are significant at p < 0.05. * Missing data: current Tobacco smoker (n = 1).
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Moodley, S.; Kroon, E.; Naidoo, C.C.; Nyawo, G.R.; Wu, B.G.; Naidoo, S.; Chiyaka, T.L.; Tshivhula, H.; Singh, S.; Li, Y.; et al. Latent Tuberculosis Infection Is Associated with an Enrichment of Short-Chain Fatty Acid-Producing Bacteria in the Stool of Women Living with HIV. Microorganisms 2024, 12, 1048. https://doi.org/10.3390/microorganisms12061048

AMA Style

Moodley S, Kroon E, Naidoo CC, Nyawo GR, Wu BG, Naidoo S, Chiyaka TL, Tshivhula H, Singh S, Li Y, et al. Latent Tuberculosis Infection Is Associated with an Enrichment of Short-Chain Fatty Acid-Producing Bacteria in the Stool of Women Living with HIV. Microorganisms. 2024; 12(6):1048. https://doi.org/10.3390/microorganisms12061048

Chicago/Turabian Style

Moodley, Suventha, Elouise Kroon, Charissa C. Naidoo, Georgina R. Nyawo, Benjamin G. Wu, Selisha Naidoo, Tinaye L. Chiyaka, Happy Tshivhula, Shivani Singh, Yonghua Li, and et al. 2024. "Latent Tuberculosis Infection Is Associated with an Enrichment of Short-Chain Fatty Acid-Producing Bacteria in the Stool of Women Living with HIV" Microorganisms 12, no. 6: 1048. https://doi.org/10.3390/microorganisms12061048

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop